Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30004451
Basic Information
VIS ID
TVIS30004451
Fusion event
HIV-TMBIM6 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr12
Cytoband
q13.12
Reference genome
GRCh37/hg19
Start
50141477/49747694 (Hg38)
End
50141477/49747694 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA12A
Target gene
TMBIM6
miRNAs that regulate target gene
hsa-mir-155-5p
;
hsa-mir-16-5p
;
hsa-mir-484
;
hsa-mir-186-5p
;
hsa-mir-19b-3p
;
hsa-mir-17-5p
;
hsa-mir-20a-5p
;
hsa-mir-93-5p
;
hsa-mir-106b-5p
;
hsa-mir-20b-5p
;
hsa-mir-519d-3p
;
hsa-mir-4533
;
hsa-mir-6782-5p
;
hsa-mir-27a-3p
;
hsa-mir-27b-3p
;
hsa-mir-144-3p
;
hsa-mir-513a-5p
;
hsa-mir-4293
;
hsa-mir-7156-3p
;
hsa-mir-19a-3p
;
hsa-mir-363-5p
;
hsa-mir-423-5p
;
hsa-mir-608
;
hsa-mir-651-3p
;
hsa-mir-1252-3p
;
hsa-mir-1914-3p
;
hsa-mir-3184-5p
;
hsa-mir-3190-3p
;
hsa-mir-4428
;
hsa-mir-4651
;
hsa-mir-5093
;
hsa-mir-5194
;
hsa-mir-548aw
;
hsa-mir-6734-5p
;
hsa-mir-6738-5p
;
hsa-mir-6745
;
hsa-mir-4424
;
hsa-mir-362-3p
;
hsa-mir-335-3p
;
hsa-mir-450a-1-3p
;
hsa-mir-329-3p
;
hsa-mir-589-3p
;
hsa-mir-3153
;
hsa-mir-6733-5p
;
hsa-mir-6739-5p
;
hsa-mir-8066
;
hsa-mir-4487
;
hsa-mir-551b-5p
;
hsa-mir-708-3p
;
hsa-mir-3160-3p
;
hsa-mir-4451
;
hsa-mir-4536-5p
;
hsa-mir-4796-3p
;
hsa-mir-6508-5p
;
hsa-mir-6832-5p
;
hsa-mir-7844-5p
;
hsa-mir-8067
;
hsa-mir-485-5p
;
hsa-mir-6884-5p
;
hsa-mir-3975
;
hsa-mir-5186
;
hsa-mir-218-5p
;
hsa-mir-1304-5p
;
hsa-mir-6765-5p
;
hsa-mir-3649
;
hsa-mir-8077
;
hsa-mir-3188
;
hsa-mir-2467-5p
;
hsa-mir-4645-3p
;
hsa-mir-4682
;
hsa-mir-4526
;
hsa-mir-3660
;
hsa-mir-4478
;
hsa-mir-4419b
;
hsa-mir-3929
;
hsa-mir-4668-5p
;
hsa-mir-3202
;
hsa-mir-1468-3p
;
hsa-mir-548x-5p
;
hsa-mir-548g-5p
;
hsa-mir-548f-5p
;
hsa-mir-548aj-5p
;
hsa-mir-4735-5p
;
hsa-mir-4528
;
hsa-mir-379-5p
;
hsa-mir-3529-5p
;
hsa-mir-4650-3p
;
hsa-mir-511-5p
;
hsa-mir-6740-3p
;
hsa-mir-558
;
hsa-mir-6837-3p
;
hsa-mir-6754-3p
;
hsa-mir-412-3p
;
hsa-mir-216a-3p
;
hsa-mir-3681-3p
;
hsa-mir-128-3p
;
hsa-mir-656-3p
;
hsa-mir-140-3p
;
hsa-mir-188-3p
;
hsa-mir-4433a-5p
;
hsa-mir-5588-3p
;
hsa-mir-6075
;
hsa-mir-873-5p
;
hsa-mir-933
Nearest miRNA
hsa-mir-1244-3/Upstream/975657; hsa-let-7i/Downstream/486448;
Nearest TSS
ENST00000382841/Upstream/4277;
ENST00000553022/Downstream/2926;
Nearest CpG islands
None/Target,
chr12-CpG: 104/Upstream/5434
,
chr12-CpG: 22/Downstream/47178
Upstream sequence
cattgtgcatggccTTTTTCCTTTTTTGTTTTTTGGAAGTGAACATAACCTTGAGACTTTATTGTCTTCATAATAAAACATAAACTGATATTTAATTAAA
Downstream sequence
TGTGCGAACAGTGTTTCTTTGACTTGCTGTTTTAATGTTGCTGTACACACTGAGGCAAAGTCTGTCTTGGCTCCAGCATTGCATAGAACGCATACTAAAT
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Bcl-2 transduced CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate